On the recordNovember 18, 2013
Mr. President, hundreds of people in Virginia were sickened and 2 died from an outbreak of fungal meningitis last year that was traced to a single compounding pharmacy in Massachusetts. Hundreds more in several States became sick, and dozens perished. This public health crisis highlighted the critical need for better oversight of pharmacies that are producing compounded drugs. The Compounding Quality Act and Drug Supply Chain Security Act, which the Senate will consider for final passage today, includes important provisions that ensures that patients and providers have access to safe compounded drugs. This legislation also includes important provisions that deal with how to better monitor and track the drug distribution supply chain. It improves on patient safety by developing a workable pathway that will ultimately result in tracing for the entire country. Additionally, it strengthens licensure requirements for wholesale distributions and third-party logistics providers, and establishes nationwide drug serial numbers. Finally, this legislation works to address the growing problem of pharmaceutical theft, counterfeiting and diversion. The Compounding Quality Act and Drug Supply Chain Security Act is the most significant piece of legislation on drug distribution supply chain in 25 years.…
Source
govinfo.gov




